Facet Life Sciences Announces Partnership with Nucleus as Official Regulatory Partner
Facet Life Sciences specializes in guiding life science companies through [...]
Understanding the Impact of the 2025 CPT Code Updates on Healthcare Innovation
By Randy Goodman, Ph.D., MHA, FACHE, PMP, BCMASThe American Medical [...]
Facet Life Sciences Named Regulatory Partner for Cybin’s Neuropsychiatry Therapeutics Development Pipeline
Facet Life Sciences, a leader in US regulatory strategy and [...]
New Draft FDA Guidance: Chemical Analysis for Biocompatibility Assessment of Medical Devices (September 20, 2024)
FDA issued a draft guidance for industry and FDA staff [...]
New FDA Guidance: Control of Nitrosamine Impurities in Human Drugs (September 2024)
FDA issued Revision 2 of the guidance for industry Control [...]
Facet Life Sciences Quarterly Update Q2 – 2024
From The Corner Office Q2 2024 Ken [...]
Facet By The Numbers – Q2 2024
FACET BY THE NUMBERS Total ESG submissions to FDA [...]
Go Team! – Q2 2024
Team Focus - New Facet Team Members We are [...]
ICYMI – Q2 2024 – SNMMI’s Mars Shot
Facet Donates to SNMMI’s Mars Shot Facet is proud [...]
ICYMI – Q2 2024 – SNMMI
Facet Attends SNMMI In June, Dr. Lisa Jenkins VanLuvanee [...]
gET sOCIAL